Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Acetylcarnitine levels were significantly lower in the MDD group compared to the control and remission groups, suggesting its potential as a diagnostic and predictive biomarker for MDD (Lee et al
& Chen, W.-D
Maryland residents recognize the urgency and embrace treatment without delay
Lilly raised full-year revenue guidance to $82 billion to $85 billion and EPS guidance to $35.5 to $37
Liraglutide improved cognition in an open-label study of mood disorders, but exenatide failed to do the same in a small RCT of schizophrenia with obesity
Consistency in measurement method matters more than absolute accuracy
US$ 22.59
US$ 28.42
US$ 26.47
US$ 28.56
US$ 29.74
US$ 20.24
